Home Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer
 

Keywords :   


Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer

2016-01-23 03:23:46| Biotech - Topix.net

's stock had its "outperform" rating restated by equities research analysts at Oppenheimer in a research report issued to clients and investors on Friday, MarketBeat reports. They currently have a $4.00 price objective on the biotechnology company's stock.

Tags: rating receives gale outperform

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.11L
26.11 2019 BBM10
26.11Disney/Pixar Spooky Night
26.11 33
26.1114
26.11[272] ELMA03
26.113D
26.11CORRATEC R.T 3 2way-Fit
More »